The Bombay HC refused to hear the petition and referred itto Supreme Court, “The Supreme Court has said issues that have pan-India effectwill be dealt with by them and pricing is a phenomenon applicable all overIndia. We are not entertaining it [PIL] as the apex court has fairly covered it.”
In other words, the Bombay HC further claimed that thepricing of the vaccine being a national-level issue, the best agency for deliberationson the same would be the apex court of India, Supreme Court.
For the time being, the petition will be withdrawn.